Advanced company searchLink opens in new window

KANDY THERAPEUTICS LIMITED

Company number 10753028

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
15 May 2019 SH08 Change of share class name or designation
15 May 2019 SH10 Particulars of variation of rights attached to shares
09 May 2019 CS01 Confirmation statement made on 2 May 2019 with updates
08 May 2019 PSC07 Cessation of Advent Life Sciences Llp as a person with significant control on 24 August 2018
28 Feb 2019 SH01 Statement of capital following an allotment of shares on 27 February 2019
  • GBP 1,870.7619
05 Feb 2019 AA Full accounts made up to 30 June 2018
11 Dec 2018 SH01 Statement of capital following an allotment of shares on 11 December 2018
  • GBP 1,867.0019
07 Sep 2018 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES09 ‐ Resolution of authority to purchase a number of shares
  • RES01 ‐ Resolution of adoption of Articles of Association
07 Sep 2018 SH01 Statement of capital following an allotment of shares on 24 August 2018
  • GBP 1,798.23190
07 Sep 2018 SH06 Cancellation of shares. Statement of capital on 24 August 2018
  • GBP 1,405.25930
07 Sep 2018 SH10 Particulars of variation of rights attached to shares
07 Sep 2018 SH08 Change of share class name or designation
07 Sep 2018 SH03 Purchase of own shares.
05 Sep 2018 AP01 Appointment of Dr Josh Richardson as a director on 24 August 2018
23 Jun 2018 AP01 Appointment of Mr Andrew Kay as a director on 6 June 2018
22 May 2018 CS01 Confirmation statement made on 2 May 2018 with updates
27 Feb 2018 PSC02 Notification of Advent Life Sciences Llp as a person with significant control on 14 September 2017
18 Dec 2017 SH01 Statement of capital following an allotment of shares on 16 November 2017
  • GBP 1,505.50930
31 Oct 2017 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
25 Oct 2017 SH01 Statement of capital following an allotment of shares on 14 September 2017
  • GBP 1,364.094905
18 Oct 2017 AP01 Appointment of Dr Iain David Dukes as a director on 14 September 2017
17 Oct 2017 AP01 Appointment of Dr Geert Jan Mulder as a director on 14 September 2017
17 Oct 2017 AP01 Appointment of Dr Saiyed Kaasim Mahmood as a director on 14 September 2017
17 Oct 2017 AP01 Appointment of Dr Mary Kerr as a director on 14 September 2017
17 Oct 2017 PSC07 Cessation of Michael Keith Trower as a person with significant control on 14 September 2017